LncRNA SNHG16 |
Cholesterol synthesizes |
SREBP2 |
Up |
Pancreatic cancer |
45
|
Lnc030 |
Cholesterol synthesizes |
SQLE |
Up |
Breast cancer |
47
|
LncRNA CASC19 |
Cholesterol uptake |
LDLR |
Up |
Non-small cell lung cancer |
48
|
LncRNA TINCR |
De novo synthesis of fatty acids |
ACLY |
Up |
Nasopharyngeal carcinoma |
77
|
LncRNA FLJ22763 |
De novo synthesis of fatty acids |
ACLY |
Down |
Gastric cancer |
78
|
LncRNA DNAJC3-AS1 |
De novo synthesis of fatty acids |
ACC/FASN |
Up |
Colorectal cancer |
87
|
LncRNA CTD-2245E15. 3 |
De novo synthesis of fatty acids |
ACC1 |
Up |
Non-small cell lung cancer |
85
|
LncRNA HAGLR |
De novo synthesis of fatty acids |
FASN |
Up |
Non-small cell lung cancer |
94
|
LncRNA HOTAIR |
De novo synthesis of fatty acids |
FASN |
Up |
Nasopharyngeal carcinoma |
96
|
LncRNA PVT1 |
De novo synthesis of fatty acids |
FASN |
Up |
Osteosarcoma |
98
|
LncRNA SNHG16 |
De novo synthesis of fatty acids |
SCD |
Up |
Colorectal cancer |
104
|
LncRNA uc.372 |
De novo synthesis of fatty acids |
ACC/FASN/SCD1 |
Up |
Liver cancer |
105
|
LncRNA UPAT |
De novo synthesis of fatty acids |
SCD1 |
Up |
Colon cancer |
107
|
LncRNA uc.372 |
Exogenous uptake of fatty acids |
CD36 |
Up |
Liver cancer |
105
|
LncRNA LNMICC |
Exogenous uptake of fatty acids |
FABP5 |
Up |
Cervical cancer |
120
|
LncRNA SNHG7 |
Oxidation of fatty acids |
ACSL1 |
Up |
Thyroid cancer |
130
|
LncRNA HULC |
Oxidation of fatty acids |
ACSL1 |
Up |
Hepatocellular carcinoma |
132
|
LncRNA NEAT1 |
Oxidation of fatty acids |
ACSL4 |
Up |
Prostate cancer |
131
|
LncRNA MACC1-AS1 |
Oxidation of fatty acids |
CPT1 |
Up |
Gastric cancer |
121
|
LncRNA HCP5 |
Oxidation of fatty acids |
CPT1 |
Up |
Gastric cancer |
142
|
LncRNA AGAP2-AS1 |
Oxidation of fatty acids |
CPT1 |
Up |
Breast cancer |
122
|
LncRNA NEAT1 |
Oxidation of fatty acids |
CPT1 |
Up |
Breast cancer |
144
|
LncRNA SPRY4-IT1 |
Synthesis of triglyceride |
Lipin-2 |
Down |
Melanoma |
150
|
LncRNA HR1 |
Synthesis of triglyceride |
SPEBP-1c |
Down |
Liver cancer |
152
|
LncRNA NEAT1 |
Degradation of triglyceride |
ATGL |
Up |
Hepatocellular carcinoma |
158
|
LncRNA Khps1 |
Phospholipid metabolism |
SphK1 |
Up |
Osteosarcoma |
169
|
LncRNA HULC |
Phospholipid metabolism |
SphK1 |
Up |
Hepatocellular carcinoma |
170
|
LINC00460 |
Phospholipid metabolism |
SphK1 |
Up |
Colorectal cancer |
171
|
LINC00460 |
Phospholipid metabolism |
SphK2 |
Up |
Papillary thyroid carcinoma |
172
|
LINC00520 |
Phospholipid metabolism |
SphK2 |
Up |
Papillary thyroid carcinoma |
173
|
LINC00511 |
Phospholipid metabolism |
PLD1 |
Up |
Cervical cancer |
178
|
LncRNA SLNCR1 |
Phospholipid metabolism |
PLA2 |
Up |
Non-small cell lung cancer |
181
|
LncRNA HULC |
Cholesterol |
FOXM1 |
Up |
Hepatocellular carcinoma |
185
|
LncRNA UCA1 |
Palmitic acid |
ERK/MMP-9 |
Up |
Gastric cancer |
190-192
|
LncRNA ANRIL |
Phospholipid |
/ |
/ |
Large cell lung cancer |
193
|